5/10/2019 Contest update
The most picked Contest stock (by 18 of 39 portfolios), FibroGen, was clobbered today after management released confusing safety data for its lead anemia drug, roxadustat. Consequently, on top of a broad stock market slump, the Contest median was significantly impacted by FGEN’s collapse.
At Friday’s close, the Contest median was up 12.10% YTD (vs. up 18.25% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 8.42% YTD (vs. up 11.52% YTD a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 16.47% YTD (vs. up 19.85% YTD a week ago), while the Nasdaq Composite Index (NCI) was up 19.32% YTD (vs. up 23.04% YTD a week ago).
BULBA’s portfolio, up 74.81% YTD, continued as Contest leader, with OHM’s portfolio, up 59.62% YTD, and HOOD’s portfolio, up 55.35% YTD, holding on to second and third place.
At Friday's close, 31 of the 39 Contest portfolios were in the green, while 24 were beating the NBI and 15 were beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 23.11% and a median YTD gain of 13.02%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: AXGT did 1-8 reverse split.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy the Mother’s Day weekend biotechies!
Peace & good health,
Bulba
5/10/19
Rank Name Profit/Loss
1 BULBA 74,810
2 OHMS 59,624
3 HOOD 55,348
4 ANDRE 52,607
5 KMASTR 42,853
6 RKRW 42,646
7 SANCTU 38,603
8 ARTHUR 35,900
9 TRONKA 31,498
10 BLADE 30,792
Week's Top 5 Gainers
Symbol 5/3/19 5/10/19 Wk.%chg.
ATNX 10.120 14.260 40.91%
RTTR 0.750 0.910 21.33%
XERS 10.630 12.500 17.59%
CMRX 2.700 3.120 15.56%
BLU.TO 1.270 1.460 14.96%
Week's Worst 5 Losers
Symbol 5/3/19 5/10/19 Wk.%chg.
ACW.AX 0.048 0.014 -70.83%
CPRX 6.060 3.140 -48.18%
PBYI 32.350 18.420 -43.06%
FGEN 49.190 36.390 -26.02%
ATRA 34.630 26.000 -24.92%
|
